HDVY Health Discovery Corporation (CE)

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

---

 

FORM 8-K

 

---

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported):  June 16, 2015

 

 

Health Discovery Corporation

(Exact name of registrant as specified in charter)

 

 

Georgia	333-62216	74-3002154
(State of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

 

 

4243 Dunwoody Club Drive, Suite 202, Atlanta GA  30350

(Address of principal executive offices / Zip Code)

 

 

(678) 336-5300

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 

	o	Written communications pursuant to Rule 425 under the Securities Act.
	o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
	o	Pre-commencement communications pursuant to Rule 14d—2(b) under the Exchange Act.
	o	Pre-commencement communications pursuant to Rule 13e—4(c) under the Exchange Act.

 

 

ITEM 8.01

Other Events

 

In January 2007, SVM Capital, LLC (“SVM Capital”) was formed as a joint venture between Health Discovery Corporation (“HDC”) and Atlantic Alpha Strategies, LLC (“Atlantic Alpha”) to explore and exploit the potential applicability of HDC’s SVM technology to quantitative investment management techniques.  On June 16, 2015, SVM Capital joined Manifold Partners, LLC (“ Manifold Partners”) as a partner.

 

On June 16, 2015, Manifold Partners issued a press release announcing SVM Capital joining Manifold Partners. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.

 

ITEM 9.01

Financial Statements and Exhibits

  

	(a)	Not applicable
	(b)	Not applicable
	(c)	Not applicable
	(d)	Exhibits
		99.1     Press Release Manifold Partners, LLC dated June 16, 2015.

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

 

	HEALTH DISCOVERY CORPORATION
Dated:  June 17, 2015	By:	/s/ Kevin Kowbel
		Chairman & Interim Chief Executive Officer

 

EXHIBIT 99.1

 

June 16, 2015

 

SVM Capital Joins Manifold Partners

 

Manifold Partners, a San Francisco-based multi-strategy portfolio management firm specializing in quantitative investment methodologies, announced today that SVM Capital has joined as a partner. This new collaboration will be known as Manifold Vector.

 

SVM Capital specializes in the application of an artificial intelligence technique known as a ‘support vector machine’ (SVM) to investment strategies. SVM Capital has developed mathematical algorithms to rank-order S&P 500 stocks to determine investment desirability, including long and short equity positions. Importantly, only fundamental corporate data is analyzed, which Manifold Partners believes to be unique in the quantitative investment field. This technology is an outgrowth of the machine learning techniques created by SVM Capital’s parent, Health Discovery Corp., in developing mathematical algorithms for medical diagnostics.

 

“We seek tested science that has not yet been applied to portfolio management,” said Jim Creighton, CIO of Manifold Partners. “Support Vector mathematical techniques have been applied successfully elsewhere and we believe the new team’s ability to adapt this to dynamic stock prices is an important advance in the science.”

 

Creighton continued, “The SVM Capital results we have tested are uncorrelated with other methods, market indices, and factor exposures. The Manifold Vector portfolio is a key element in Manifold’s growing set of innovative investment methodologies. SVM Capital’s proprietary technology and methods promise to improve investment outcomes as new fundamental data is used to build a large proprietary dataset from which to draw portfolios.”

 

Dr. Mark Moore, Ph.D., the head of the Manifold Vector team, commented, “Support vector machine approaches have proven useful in myriad applications, from medical diagnostics to differentiation of very large classes of ‘big data’. For over five years we have been studying the application of these techniques to U.S. equity portfolios and we believe our partnership with Manifold will permit our team to continue to build new and effective algorithm suites for a wide variety of investment applications.”

 

Dr. Moore and Dr. Hong Zhang, along with Manifold Partners researchers, will comprise the Manifold Vector team.

 

•

Dr. Moore earned his B.A. in Science and Philosophy from Florida Atlantic University and his Ph.D. in Mathematical Logic and Philosophy from the University of Tennessee. He led Moore & Associates from 1979 to 1984, co-founded Codeworks Corporation in 1987, and was a General Partner of the $11 billion Millennium Partners Hedge Fund from 1988 to 1992, among other accomplishments.

 

•

Dr. Zhang has a B.S. in Computer Science from Fudan University and an M.S.E.E. as well as an M.A. and a Ph.D. from the University of Pittsburgh in Mathematics. He taught Mathematical Sciences at Purdue University from 1989 to 1996, served as a Research Scientist for a number of medical diagnostic firms, and teaches Computer Science and serves as Department Head of Computer Science and Information Technology at Armstrong State University.

 

“We are excited to bring new science to tough problems for the benefit of our investors,” said Donald H. Putnam, CEO of Manifold Partners. “We expect to launch Manifold Vector portfolios for our institutional and fund clients by the end of the year.”

 

The new SVM Capital team is the third at Manifold Partners, which was launched in 2013 by Grail Partners and the Cluster Analysis team from Creighton Capital. In 2014, Dr. Simon Nocera and his team from Lumen Partners joined Manifold to establish a Global Macro Value Team.